Ambu Archives - Page 2 of 3 - Medical Design Sourcing

Ambu replaces CEO with new leadership

Britt Meelby Jensen is the new CEO of Ambu (Photo via Atos Medical)

Ambu today said it has hired board member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez, effective tomorrow.

“Since Juan Jose Gonzalez joined as CEO in 2019, Ambu has made good progress and achieved important milestones on the strategic transformation into the world’s largest single-use endoscopy company,” Ambu Chair Jørgen Jensen said in a news release. “However, the COVID-19 pandemic, the recent macroeconomic headwind and a weaker than originally expected financial performance require that we execute differently on our strategy.”

Jørgen Jensen said Ambu’s overall strategic direction has not changed but that the board, Britt Meelby Jensen and her leadership team will “evaluate the need for tactical and operational adjustments to the strategy.”

Get the full story at our sister site, MassDevice.

Ambu replaces CEO with new leadership

Britt Meelby Jensen is the new CEO of Ambu (Photo via Atos Medical)

Ambu today said it has hired Board Member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez effective tomorrow.

“Since Juan Jose Gonzalez joined as CEO in 2019, Ambu has made good progress and achieved important milestones on the strategic transformation into the world’s largest single-use endoscopy company,” Ambu Chair Jørgen Jensen said in a news release. “However, the COVID-19 pandemic, the recent macroeconomic headwind and a weaker than originally expected financial performance require that we execute differently on our strategy.”

Jørgen Jensen said Ambu’s overall strategic direction has not changed, but that the board, Britt Meelby Jensen and her leadership team will “evaluate the need for tactical and operational adjustments to the strategy.”

“With more than 20 years of experience within healthcare and general management, and her work o…

Thanks, mom! Medtech leaders reflect on Mother’s Day

[Photo from Aditya Romansa on Unsplash]Everyone has a story about how they got into medtech, and it’s no surprise that many of those stories start with how we were raised.

As Mother’s Day approaches, Medical Design & Outsourcing asked medtech leaders to share some thoughts about how their moms inspired their careers, the products they make and the companies they’ve built.

We can never say “thanks” often enough to truly show our gratitude – but one more time can’t hurt.

Get the full story at our sister site, Medical Design & Outsourcing.

Ambu makes single-use scopes available for swallowing evaluation procedures

Ambu says its single-use aScope 4 RhinoLaryngo Slim and aView 2 Advance HD monitor provide a portable way to perform bedside swallowing evaluations (FEES) in healthcare settings. [Image courtesy of Ambu]Ambu today announced new capabilities for its single-use aScope 4 RhinoLaryngo Slim and aView 2 Advance HD monitor.

The new capabilities bring Ambu single-use endoscopy to bear on fibreoptic endoscopic evaluation of swallowing (FEES) procedures, which Ambu officials take place more than 1 million times a year across key markets in North America, Europe and the Asia-Pacific region.

“FEES procedures represent a large and growing area for patient care, one which has become even more important since Covid-19, and one where single-use endoscopy can play an important role,” said Bassel Rifai, Ambu’s chief marketing officer.

The FEES procedure requires a flexible rhinolaryngoscope to assess swallowing physiology and function for people with trouble swallowing…

FDA clears Ambu’s single-use gastroscope and next-gen display unit

[Image from Ambu]Ambu announced today that it received FDA 510(k) clearance for its Ambu aScope Gastro and Ambu aBox 2 platforms.

Columbia, Maryland-based Ambu designed the aScope Gastro as its first sterile, single-use gastroscope with new advanced imaging and design features in a combined offering with next-generation display and processor technology. The aBox 2 includes HD capabilities to improve image quality at the heart of Ambu’s endoscopy ecosystem.

According to a news release, the launch of the aScope Gastro platform allows Ambu to enter into the gastroscopy segment with a single-use scope, offering advanced technology, portability and cost-effectiveness compared to the reusable endoscopes that dominate the space.

The company said aScope Gastro will support healthcare systems in reducing waiting lists and overcoming staff shortages, too, amid issues that have persisted since the COVID-19 pandemic began. It also provides a solution to cross-con…

Ambu awarded single-use endoscopy contract with Vizient

Ambu today announced that it has been awarded a contract for single-use visualization devices with Vizient, effective Feb. 1, 2022.

The contract will help Ballerup, Denmark-based Ambu expand its single-use endoscope market by offering Vizient members pre-negotiated pricing and terms for Ambu’s single-use products, which include bronchoscopy, urology, ENT and GI. The agreement also includes access to all new single-use endoscope launches.

Get the full story on our sister site, Medical Tubing & Extrusion.

How medtech fared in the first waves of the pandemic

[Photo by Martin Sanchez on Unsplash]Medtech industry revenue, research spending and employment declined in the first year of the COVID-19 pandemic, according to a Medical Design & Outsourcing analysis of financial data.

Total sales, R&D spending and employment for the world’s largest medical device companies declined in 2020 and early 2021, according to a Medical Design & Outsourcing analysis tallying the ongoing pandemic’s initial toll on the industry.

To compare performance before and during the pandemic, MDO used the financial data that we’ve historically gathered to rank our Big 100 companies in the last three years. The majority of these companies reported full-year results for 2020; others operate on a fiscal year and reported annual results in the first half of 2021.

Some companies are not in this year’s Big 100 but were included in the analysis because they were ranked in pre-pandemic years. The handful of companies that joined this yea…

How medtech fared in the first waves of the pandemic

[Photo by Martin Sanchez on Unsplash]

Medtech industry revenue, research spending and employment declined in the first year of the COVID-19 pandemic, according to a Medical Design & Outsourcing analysis of financial data.

Total sales, R&D spending and employment for the world’s largest medical device companies declined in 2020 and early 2021, according to a Medical Design & Outsourcing analysis tallying the ongoing pandemic’s initial toll on the industry.

To compare performance before and during the pandemic, MDO used the financial data that we’ve historically gathered to rank our Big 100 companies in the last three years. The majority of these companies reported full-year results for 2020; others operate on a fiscal year and reported annual results in the first half of 2021.

Some companies are not in this year’s Big 100 but were included in the analysis because they were ranked in pre…

Study finds single-use bronchoscopes reduce hospital readmission rates by half

The Ambu aScope4 single-use bronchoscope [Photo courtesy of Ambu]A study of 14,228 bronchoscopy procedures found sterile, disposable scopes reduced readmission rates by more than half.

The study, authored by Ambu consultant Dr. Hudson Garrett, analyzed procedures at inpatient hospitals as well as outpatient ambulatory facilities.

He found that 3.6 percent of patients treated with a single-use, flexible bronchoscope were readmitted within 30 days, compared to 7.7 percent of patients whose procedures used reusable scopes.

Get the full story at our sister site, Medical Design & Outsourcing.

Study finds single-use bronchoscopes reduce hospital readmission rates by half

The Ambu aScope4 single-use bronchoscope [Photo courtesy of Ambu]

A study of 14,228 bronchoscopy procedures found sterile, disposable scopes reduced readmission rates by more than half.

The study, authored by Ambu consultant Dr. Hudson Garrett, analyzed procedures at inpatient hospitals as well as outpatient ambulatory facilities.

He found that 3.6 percent of patients treated with a single-use, flexible bronchoscope were readmitted within 30 days, compared to 7.7 percent of patients whose procedures used reusable scopes.

“The data analysis demonstrates significant clinical benefits of single-use bronchoscopes in reducing readmission rates and patient risk,” Garrett said in an Ambu news release. “To reduce these risks, the use of sterile single-use bronchoscopes should be considered to eliminate reprocessing failures, improve overall operational efficiency and reduce potential acquisition of healt…

Ambu secures CE mark for single-use bronchoscope and sampling system

Ambu recently announced that its single-use bronchoscope and specimen sampling system won CE mark approval.

Ambu’s aScope 4 Broncho sampler set is a sterile, single-use device for bronchial wash and bronchoalveolar lavage procedures.

Get the full story on our sister site, Medical Tubing + Extrusion.

Ambu nabs Health Canada clearance for single-use cystoscope

Ambu (CPH:AMBU-B) today said it received Health Canada clearance for its aScope 4 Cysto single-use cystoscope.

The cystoscope is a flexible, single-use endoscope that is designed to eliminate significant capital, repair and cleaning costs with a patient-ready instrument for every procedure, according to Ambu. The device is used for diagnosing, managing and treating lower urinary disorders such as hematuria, incontinence and bladder cancer.

Get the full story on our sister site, Medical Tubing + Extrusion.